Trial Condition(s):

Prevention of venous thromboembolism after MOS

BAY59-7939, ER, Prototype IV

Bayer Identifier:

12571

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2010-022937-27

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
N/A
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Xarelto (Rivaroxaban, BAY59-7939)
Accepts Healthy Volunteers
N/A

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Bayer HealthCare

Wuppertal, Germany, 42096

Status
Completed
 

For details, please refer to trial results

Additional Information